Davidson Kempner Capital Management »

Cidara Therapeutics shares owned by Davidson Kempner Capital Management

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by Davidson Kempner Capital Management from 13F filings

Historical chart of Davidson Kempner Capital Management investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by Davidson Kempner Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by Davidson Kempner Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $34M 156k 220.89

More positions owned by Davidson Kempner Capital Management

Spdr S&p 500 Etf Tr Tr Unit Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Russell 2000 Etf Russell 2000 Etf Put Option (IWM)
Alibaba Group Hldg Note 0.500% 6/1/31 (Principal)
Rivian Automotive Note 4.625% 3/1 (Principal)
Ceridian Hcm Hldg
Uber Technologies Note 0.875%12/0 (Principal)
Confluent Note 1/15/27 (Principal)
Arko Corp (ARKO)
Redfin Corp Note 0.500% 4/0 (Principal)
Ford Mtr Note 0.0% 3/15/26 (Principal)
Echostar Corp Cl A Cl A (SATS)
Li Auto Note 0.250% 5/0 (Principal)
Snowflake Note 0% 10/0 (Principal)
Trip Com Group Note 0.750% 6/1 (Principal)

View all positions for Davidson Kempner Capital Management

Top funds holding Cidara Therapeutics

RA Capital Management
Vanguard Group
BlackRock
BVF
UBS Group
Darwin Global Management
Vivo Capital
State Street Corporation
Susquehanna International
FMR
Leucadia National Corporation
Paradigm Biocapital Advisors
Citadel Advisors
Henderson Group
Glazer Capital

View all funds holding Cidara Therapeutics